KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Copart (CPRT) Asset Writedowns and Impairment (2016 - 2026)

Copart (CPRT) has disclosed Asset Writedowns and Impairment for 18 consecutive years, with $126000.0 as the latest value for Q1 2026.

  • On a quarterly basis, Asset Writedowns and Impairment rose 431.58% to $126000.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $1.4 million, a 10.49% increase, with the full-year FY2025 number at $354000.0, down 90.96% from a year prior.
  • Asset Writedowns and Impairment was $126000.0 for Q1 2026 at Copart, down from $2.0 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $2.7 million in Q1 2024 to a low of -$1.2 million in Q2 2024.
  • A 5-year average of $551235.3 and a median of $466000.0 in 2023 define the central range for Asset Writedowns and Impairment.
  • Biggest YoY gain for Asset Writedowns and Impairment was 535.51% in 2023; the steepest drop was 173.22% in 2023.
  • Copart's Asset Writedowns and Impairment stood at $1.4 million in 2022, then decreased by 24.86% to $1.0 million in 2023, then increased by 4.29% to $1.1 million in 2024, then surged by 80.71% to $2.0 million in 2025, then crashed by 93.63% to $126000.0 in 2026.
  • Per Business Quant, the three most recent readings for CPRT's Asset Writedowns and Impairment are $126000.0 (Q1 2026), $2.0 million (Q4 2025), and $201000.0 (Q3 2025).